By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biolex, Inc. 

158 Credle Street

Pittsboro  North Carolina  27312  U.S.A.
Phone: 919-542-9901 Fax: 919-542-9910


Company News
OctoPlus' Licensee Biolex, Inc. Makes Third Presentation At EASL Confirming Locteron's Superior Product Profile 4/19/2010 10:15:15 AM
Biolex, Inc. Pulls Planned IPO Due to Market Conditions 2/4/2008 7:03:41 AM
Biolex, Inc. Announces Initiation Of Locteron(TM) Phase 2 Clinical Study In Chronic Hepatitis C 1/30/2007 11:17:01 AM
Biolex, Inc. Announces Publication In Nature Biotechnology Demonstrating Potential To Produce Monoclonal Antibodies With Increased Potency And Efficacy 11/28/2006 10:48:12 AM
Biolex, Inc. Featured At The 9th Annual Facilities For Mammalian Cell Product Conference 10/18/2006 11:08:16 AM
Biolex Therapeutics Announces Positive Phase 1 Results For Hepatitis C Product Candidate Locteron(TM) 4/27/2006 10:19:30 AM
Biolex Therapeutics Announces Expansion Of Medarex, Inc. (MEDX) Collaboration 4/11/2006 10:31:46 AM
Biolex Therapeutics Receives Prestigious Award For Manufacturing Facility 3/22/2006 11:17:43 AM
Biolex Therapeutics Presents Results Highlighting Benefits Of Locteron(TM) At 'Breakthroughs In Hepatitis' Session 2/15/2006 10:42:45 AM
Biolex Therapeutics Announces Recruitment Of Three Key Management Team Additions To Accelerate Commercialization Of Lead Programs 11/16/2005 11:56:01 AM